DavidPWarshalMD

Obstetrics & Gynecology • Camden, NJ

Gynecologic Oncology

Associate Professor, Obstetrics and Gynecology, Cooper Medical School of Rowan Univ

Join to view full profile

Dr. Warshal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Warshal's full profile

Already have an account?

Office
2 Cooper Plaza 400 Haddon Ave
Camden, NJ 08103
Phone+1 855-632-2667
Is this information wrong?

Education & Training

University of RochesterFellowship, Gynecologic Oncology, 1992 - 1994
University of RochesterResidency, Obstetrics and Gynecology, 1987 - 1991
Nassau University Medical CenterInternship, Internal Medicine, 1986 - 1987
Pennsylvania State University College of MedicineClass of 1986

Certifications & Licensure

NJ State Medical License 1997 - 2025
PA State Medical License 1991 - 2024
NY State Medical License 1988 - 1994
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Inside Jersey Top Doctors for Cancer Castle Connolly, 2012-2014
Inside Jersey Magazine Top Doctors Castle Connolly, 2010-2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Inside Jersey - Top Doctors for Women's Health Castle Connolly, 2010-2012
Philadelphia Magazine Castle Connolly, 2009-2012
Top MD Consumers Checkbook
Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Most Compassionate Doctor American Registry
Join now to see all

Clinical Trials

Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25
Active, not recruiting
Phase 2
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
Active, not recruiting
Phase 3
Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2010 Dec 13
Completed
Phase 2
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Start of enrollment: 2012 Jan 09
Completed
Phase 3
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery Start of enrollment: 2012 Jun 04
Terminated
Phase 3
Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva Start of enrollment: 2012 Jul 02
Active, not recruiting
Phase 2
Psychological Interventions for Gynecologic Cancer Start of enrollment: 2010 Jun 01
Completed
Not Applicable
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer Start of enrollment: 2014 Mar 17
Active, not recruiting
Phase 2, Phase 3
Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian Start of enrollment: 2020 Jun 09
Active, not recruiting
Phase 2
Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer Start of enrollment: 2015 Sep 23
Active, not recruiting
Phase 2
Roles: Contact, Principal Investigator
IMGN853 With Carboplatin in Second-line Treatment of FRα Expressing, Platinum-sensitive Epithelial Ovarian Cancer Start of enrollment: 2022 Sep 28
Recruiting
Phase 2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

2 citations
The Effects of Natural Epigenetic Therapies in 3D Ovarian Cancer and Patient-Derived Tumor Explants: New Avenues in Regulating the Cancer Secretome.
Rebeca Kelly, Diego Aviles, Catriona Krisulevicz, Krystal Hunter, Lauren Krill, David Warshal, Olga Ostrovsky> ;Biomolecules. 2023 Jul 1
2 citations
Implementation and outcome evaluations of a multi-site improvement program in cancer genetics.
Erica M Bednar, Blake Harper, Michael T Walsh Jr, Ruth Rechis, Michelle Bilbao, Rebecca L Carr, Amanda L Eppolito, Timothy Goedde, Brooke Levin, Kristin Mattie, Nichol...> ;Journal of Genetic Counseling. 2023 Feb 1
28 citations
Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial.
Matthew A Powell, Virginia L Filiaci, Martee L Hensley, Helen Q Huang, Kathleen N Moore, Krishnansu S Tewari, Larry J Copeland, Angeles A Secord, David G Mutch, Alessa...> ;Journal of Clinical Oncology. 2022 Mar 20
4 citations
Epigenetic Therapy Augments Classic Chemotherapy in Suppressing the Growth of 3D High-Grade Serous Ovarian Cancer Spheroids over an Extended Period of Time.
Michelle Bilbao, Chelsea Katz, Stephanie L. Kass, Devon Smith, Krystal Hunter, David P. Warshal, James K. Aikins, Olga Ostrovsky> ;Biomolecules. 2021 Nov 17
11 citations
Can Cannabidiol Affect the Efficacy of Chemotherapy and Epigenetic Treatments in Cancer
Courtney Griffiths, James K. Aikins, David Warshal, Olga Ostrovsky> ;Biomolecules. 2021 May 20
116 citations
Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209).
David Miller, Virginia L. Filiaci, Robert S. Mannel, David E. Cohn, Takashi Matsumoto, Krishnansu S. Tewari, Paul DiSilvestro, Michael L. Pearl, Peter A. Argenta, Matt...> ;Journal of Clinical Oncology. 2020 Sep 29
5 citations
Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic ...
Peter G. Rose, James J. Java, Mark A. Morgan, A. Alvarez-Secord, Joshua Kesterson, Frederick B. Stehman, David P. Warshal, William T. Creasman, Parviz Hanjani, Robert ...> ;Gynecologic Oncology. 2016 Dec 1
5 citations
A phase II evaluation of ixabepilone in the treatment of recurrent/persistent carcinosarcoma of the uterus, an NRG Oncology/Gynecologic Oncology Group study.
Carolyn K. McCourt, Wei Deng, Don S. Dizon, Heather A. Lankes, Michael J. Birrer, Michele M. Lomme, Matthew A. Powell, James E. Kendrick, Joel N. Saltzman, David P. Wa...> ;Gynecologic Oncology. 2017 Jan 1
44 citations
Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study
John A. Blessing, Lisa M. Landrum, David P. Warshal, Lainie P. Martin, Stephen L. Rose, Albert J. Bonebrake, Lois M. Ramondetta, David S. Alberts> ;Gynecologic Oncology. 2012 Dec 1
Cyclin D1 and p57 expression in advanced ovarian epithelial carcinoma: A GOG study.
Hill E, Brady W, Birrer MJ, Darcy KM, McGuire WP, Hoskins WJ, Warshal DP, Drake RD, Hanjani P, Hurteau J> ;J. Clin. Oncol.. 2011-05-20
11 citations
A Phase 2 Evaluation of Irofulven as Second-line Treatment of Recurrent or Persistent Intermediately Platinum-Sensitive Ovarian or Primary Peritoneal Cancer A Gynecolo...
Russell J. Schilder, John A. Blessing, Mark S. Shahin, David Miller, Krishnansu S. Tewari, Carolyn Y. Muller, David P. Warshal, Scott McMeekin, Jacob Rotmensch> ;International Journal of Gynecological Cancer. 2010 Oct 1
3 citations
A phase I trial of dose-dense (biweekly) carboplatin combined with paclitaxel and pegfilgrastim: a feasibility study in patients with untreated Stage III and IV ovaria...
Amy Tiersten, Michael W. Sill, Danielle Knight, Franco M. Muggia, Agustin A. Garcia, Ron E. Swensen, David P. Warshal, Robert S. Mannel, Paula M. Fracasso> ;Gynecologic Oncology. 2010 Sep 1
21 citations
A phase II evaluation of weekly gemcitabine and docetaxel for second-line treatment of recurrent carcinosarcoma of the uterus: a gynecologic oncology group study.
Brigitte Miller, John A. Blessing, Frederick B. Stehman, Mark S. Shahin, S. Diane Yamada, Angeles Alvarez Secord, David P. Warshal, Ovadia Abulafia, William E. Richard...> ;Gynecologic Oncology. 2010 Aug 1
27 citations
Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: a Gyne...
John H. Farley, Sartoru Fuchiuji, Kathleen M. Darcy, Chunqiao Tian, William J. Hoskins, William McGuire, Parviz Hanjani, David P. Warshal, Benjamin E. Greer, Jerome L....> ;Gynecologic Oncology. 2009 Jun 1
Phase I/feasibility trial of dose-dense carboplatin (C) and paclitaxel (P) in patients (pts) with ovarian cancer: A Gynecologic Oncology Group study.
Tiersten A, Sill M, Muggia F, Elera C, Garcia A, Fracasso P, Swensen R, Warshal D, Mannel R> ;J. Clin. Oncol.. 2009-05-20
11 citations
Phase II multicenter open-label study of karenitecin in previously treated epithelial ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.
John J. Kavanagh, M. Sill, David P. Warshal, Michael L. Pearl, Mark A. Morgan> ;International Journal of Gynecological Cancer. 2008 May 1
27 citations
Radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in cervical carcinoma limited to the pelvis: a phase I/II study of the Gynecologic Oncology Gr...
Paul DiSilvestro, Joan L. Walker, Astrid Morrison, Peter G. Rose, Howard D. Homesley, David Warshal> ;Gynecologic Oncology. 2006 Dec 1
4 citations
Pain evaluation in patients receiving intravenous patient-controlled analgesia after surgery.
Ghassem E. Larijani, Imran Sharaf, David P. Warshal, Alex Marr, Irwin Gratz, Michael E. Goldberg> ;Pharmacotherapy. 2005 Sep 1
12 citations
Analgesic and hemodynamic effects of a single 7.5-mg intravenous dose of morphine in patients with moderate-to-severe postoperative pain.
Ghassem E. Larijani, Michael E. Goldberg, Irwin Gratz, David P. Warshal> ;Pharmacotherapy. 2004 Dec 1
129 citations
Prevalence and Predictors of Psychological Distress Among Women With Ovarian Cancer
Tina R. Norton, Sharon L. Manne, Stephen C. Rubin, John A. Carlson, Enrique Hernandez, Mitchell I. Edelson, Norman G. Rosenblum, David Warshal, Cynthia Bergman> ;Journal of Clinical Oncology. 2004 Mar 1
120 citations
A phase II study of docetaxel in paclitaxel-resistant ovarian and peritoneal carcinoma: a Gynecologic Oncology Group study
Peter G. Rose, John A. Blessing, Harrison G. Ball, James S. Hoffman, David Warshal, Koen DeGeest, David H. Moore> ;Gynecologic Oncology. 2003 Feb 1
9 citations
Post-hysterectomy fallopian tube carcinoma presenting with a positive Papanicolaou smear
David P. Warshal, Elise R Burgelson, James K. Aikins, Thomas Rocereto> ;Obstetrics and Gynecology. 1999 Nov 1
19 citations
Ovarian cancer: comparison of observer performance for four methods of interpreting CT scans.
Patrick J. Fultz, Christina V. Jacobs, W. Jackson Hall, Ronald H. Gottlieb, Deborah J. Rubens, Saara Totterman, Steven P. Meyers, Cynthia Angel, Giuseppe Del Priore, D...> ;Radiology. 1999 Aug 1
2 citations
Interstitial pregnancy complicated by rectal bleeding
David P. Warshal, Patrick J. Fultz, Andrea E. Dawson, Giuseppe Del Priore, Brent DuBeshter> ;American Journal of Obstetrics and Gynecology. 1996 Nov 1
11 citations
Colposcopic biopsies versus loop electrosurgical excision procedure cone histology in human immunodeficiency virus-positive women.
Del Priore G, Gilmore Pr, Maag T, Warshal Dp, Cheon Th> ;The Journal of Reproductive Medicine. 1996 Sep 1
Join now to see all

Press Mentions

Top Physicians 2018February 27th, 2019

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

Cooper University Health CareCamden, New Jersey
Holy Redeemer HospitalJenkintown, Pennsylvania